Cover Image

Editorial: Real-world experience with CFTR modulator therapy

Saved in:

Bibliographic Details
Main Authors:	Burkhard Tümmler (Author), Pierre-Régis Burgel (Author)
Format:	Book
Published:	Frontiers Media S.A., 2023-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Post-approval studies with the CFTR modulators Elexacaftor-Tezacaftor-Ivacaftor
by: Burkhard Tümmler, et al.
Published: (2023)

An association study on contrasting cystic fibrosis endophenotypes recognizes <it>KRT8 </it>but not <it>KRT18 </it>as a modifier of cystic fibrosis disease severity and CFTR mediated residual chloride secretion
by: Becker Tim, et al.
Published: (2011)

Differential effects of ELX/TEZ/IVA on organ-specific CFTR function in two patients with the rare CFTR splice mutations c.273+1G>A and c.165-2A>G
by: Sophia T. Pallenberg, et al.
Published: (2023)

CFTR Modulator Therapy for Rare CFTR Mutants
by: Marco Mergiotti, et al.
Published: (2022)

Airway Inflammatory/Immune Responses in COPD and Cystic Fibrosis
by: Virginia De Rose, et al.
Published: (2018)

Real-world disparities and ethical considerations with access to CFTR modulator drugs: Mind the gap!
by: M. Zampoli, et al.
Published: (2023)

Real-life impact of highly effective CFTR modulator therapy in children with cystic fibrosis
by: Margarete Olivier, et al.
Published: (2023)

Airway Epithelial Inflammation In Vitro Augments the Rescue of Mutant CFTR by Current CFTR Modulator Therapies
by: Martina Gentzsch, et al.
Published: (2021)

Le miracle athénien au XXe siècle
by: Burgel, Guy
Published: (2002)

Gene Therapy: A Possible Alternative to CFTR Modulators?
by: J. Mercier, et al.
Published: (2021)

Changes in cystic fibrosis transmembrane conductance regulator protein expression prior to and during elexacaftor-tezacaftor-ivacaftor therapy
by: Frauke Stanke, et al.
Published: (2023)

Optimizing CFTR modulator therapy management for cystic fibrosis through the ReX platform
by: Karin Yaacoby-Bianu, et al.
Published: (2023)

Cystic fibrosis, with a focus on new therapies for causal treatment - CFTR protein modulators
by: Klara Iwaniszyn-Zapołoch, et al.
Published: (2022)

Nutritional impact of CFTR modulators in children with cystic fibrosis
by: Margaux Gaschignard, et al.
Published: (2023)

Molecular Mechanism of Action of Trimethylangelicin Derivatives as CFTR Modulators
by: Onofrio Laselva, et al.
Published: (2018)

Changes in vitamins and trace elements after initiation of highly effective CFTR modulator therapy in children and adults with cystic fibrosis - a real-life insight
by: Dorit Fabricius, et al.
Published: (2024)

The effect of CFTR modulators on structural lung disease in cystic fibrosis
by: L. Clara Mok, et al.
Published: (2023)

CFTR modulators: Shedding light on precision medicine for cystic fibrosis
by: Miquéias Lopes-Pacheco
Published: (2016)

Triplet CFTR modulators: future prospects for treatment of cystic fibrosis
by: Chaudary N
Published: (2018)

Effort-reward imbalance and one-year change in neck-shoulder and upper extremity pain among call center computer operators
by: Niklas Krause, et al.
Published: (2010)

Weight increase in people with cystic fibrosis on CFTR modulator therapy is mainly due to increase in fat mass
by: Marialena Mouzaki, et al.
Published: (2023)

CFTR Modulator Therapy Enhances Peripheral Blood Monocyte Contributions to Immune Responses in People With Cystic Fibrosis
by: Katherine B. Hisert, et al.
Published: (2020)

CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
by: Miquéias Lopes-Pacheco
Published: (2020)

Modulation of the Endocannabinoid System as a Potential Anticancer Strategy
by: Robert Ramer, et al.
Published: (2019)

Large genomic rearrangements in the <it>CFTR </it>gene contribute to CBAVD
by: Guittard Caroline, et al.
Published: (2007)

Modulators of CFTR protein function in the treatment of cystic fibrosis - a literature review
by: Dariusz Chojęta, et al.
Published: (2022)

Pharmacological rescue of the G85E CFTR variant by preclinical and approved modulators
by: Valeria Tomati, et al.
Published: (2024)

The Exocrine Pancreas in Cystic Fibrosis in the Era of CFTR Modulation: A Mini Review
by: Isabelle R. McKay, et al.
Published: (2022)

Peace Through Law The Versailles Peace Treaty and Dispute Settlement After World War I
by: Hess, Burkhard
Published: (2019)

State of the Art on Approved Cystic Fibrosis Transmembrane Conductance Regulator (<i>CFTR</i>) Modulators and Triple-Combination Therapy
by: Aniello Meoli, et al.
Published: (2021)

Development of CFTR structure
by: Anna E Patrick, et al.
Published: (2012)

CFTR Modulator Therapy with Lumacaftor/Ivacaftor Alters Plasma Concentrations of Lipid-Soluble Vitamins A and E in Patients with Cystic Fibrosis
by: Olaf Sommerburg, et al.
Published: (2021)

Editorial: Pharmacology of L-Arginine and L-Arginine-Rich Food
by: Burkhard Poeggeler, et al.
Published: (2021)

Association between occupational exposure and the clinical characteristics of COPD
by: Caillaud Denis, et al.
Published: (2012)

Investigating the Implications of CFTR Exon Skipping Using a Cftr Exon 9 Deleted Mouse Model
by: Kelly M. Martinovich, et al.
Published: (2022)

Real-world insight on apremilast therapy in patients with plaque psoriasis: Indian experience
by: Abhishek De, et al.
Published: (2020)

Treatment With LAU-7b Complements CFTR Modulator Therapy by Improving Lung Physiology and Normalizing Lipid Imbalance Associated With CF Lung Disease
by: Amanda Centorame, et al.
Published: (2022)

Elexacaftor-Tezacaftor-Ivacaftor: A Life-Changing Triple Combination of CFTR Modulator Drugs for Cystic Fibrosis
by: Mafalda Bacalhau, et al.
Published: (2023)

Editorial: Real world evidence, outcome research and healthcare management improvement through real world data (RWD)
by: Carolina Varela-Rodríguez, et al.
Published: (2023)

Einkommensorientierte Foerderung des sozialen Mietwohnungsbaues Bestandsaufnahme und Kritik
by: Pahnke, Burkhard
Published: (2018)